Interleukin-12 activated CD8+ T cells induces apoptosis in breast cancer cells and reduces tumor growth

被引:20
|
作者
Yang, Shi-Xin [1 ]
Wei, Wen-Song [1 ]
Ouyan, Qian-Wen [1 ]
Jiang, Qi-Hua [1 ]
Zou, Yu-Feng [1 ]
Qu, Wei [1 ]
Tu, Jian-Hong [1 ]
Zhou, Zhi-Bing [1 ]
Ding, Hao-Long [1 ]
Xie, Chun-Wei [1 ]
Lei, Qiu-Mo [1 ]
Zhong, Cheng-Ren [1 ]
机构
[1] Breast Hosp Jiangxi, Hosp Nanchang 3, Dept Galactophore, 2 Xiangshan Rd, Nanchang City 330009, Jiangxi, Peoples R China
关键词
Breast cancer; CD8(+) cells; Interleukin-12; Interferon-gamma; 4T1; cells; ANTITUMOR-ACTIVITY; IFN-GAMMA; LYMPHOCYTES; RESPONSES; IL-10; MODEL;
D O I
10.1016/j.biopha.2016.10.046
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
During the past two decades, cytokines have emerged as key molecules to modulate innate and adaptive immunity and mediate anti-tumor activity. Although multiple cytokine types are implicated for such anti-tumor activity in several cancer types, it remains largely unknown in breast cancer. In this study, cytokines that are prior known for antitumor activity in different cancer types were examined against breast cancer using a 4T1 cells based xenograft-model. Our results showed Interleukin-12 (IL-12) (500 ng/mouse) significantly suppressed the growth of tumors, while other cytokines showed minimal suppression. Subsequent molecular analysis by flow cytometry and immunohistochemistry confirmed the CD8(+) cells infiltration and Interferon-gamma (IFN-gamma) production by them in tumor environment. In addition, we observed that IFN-gamma production by activated CD8(+) cells directly induced apoptosis in tumor cells, which together indicate that IL-12 causes CD8(+) cells to infiltrate and secrete IFN-gamma in tumor environment, which induce apoptosis in them and causes tumor growth suppression. Furthermore, we showed that lower dosage of IL-12 and chemotherapy drug tamoxifen combinations enhanced the tumor suppression as opposed to single treatments, and thereby propose an alternate option for high dosage associated effects for both drug and cytokine treatments. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1466 / 1471
页数:6
相关论文
共 50 条
  • [1] Characterization of tumor-responsive CD4+ and CD8+ T cells under the influence of Interleukin-12
    Ponzio, Nicholas M.
    Singh, Parul
    Cutro, Scott
    Li, Yu
    Gasinu, Selom
    Tsiagbe, Vincent K.
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells
    Mark P. Rubinstein
    Ee Wern Su
    Samantha Suriano
    Colleen A. Cloud
    Kristina Andrijauskaite
    Pravin Kesarwani
    Kristina M. Schwartz
    Katelyn M. Williams
    C. Bryce Johnson
    Mingli Li
    Gina M. Scurti
    Mohamed L. Salem
    Chrystal M. Paulos
    Elizabeth Garrett-Mayer
    Shikhar Mehrotra
    David J. Cole
    Cancer Immunology, Immunotherapy, 2015, 64 : 539 - 549
  • [3] Interleukin-12 enhances the function and anti-tumor activity in murine and human CD8+ T cells
    Rubinstein, Mark P.
    Su, Ee Wern
    Suriano, Samantha
    Cloud, Colleen A.
    Andrijauskaite, Kristina
    Kesarwani, Pravin
    Schwartz, Kristina M.
    Williams, Katelyn M.
    Johnson, C. Bryce
    Li, Mingli
    Scurti, Gina M.
    Salem, Mohamed L.
    Paulos, Chrystal M.
    Garrett-Mayer, Elizabeth
    Mehrotra, Shikhar
    Cole, David J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (05) : 539 - 549
  • [4] Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells
    Muraoka, Daisuke
    Kato, Takuma
    Wang, Linan
    Maeda, Yuka
    Noguchi, Takuro
    Harada, Naozumi
    Takeda, Kazuyoshi
    Yagita, Hideo
    Guillaume, Philippe
    Luescher, Immanuel
    Old, Lloyd J.
    Shiku, Hiroshi
    Nishikawa, Hiroyoshi
    JOURNAL OF IMMUNOLOGY, 2010, 185 (06): : 3768 - 3776
  • [5] Characterization of a novel subset of CD8+ T cells that expands in patients receiving interleukin-12
    Gollob, JA
    Schnipper, CP
    Orsini, E
    Murphy, E
    Daley, JF
    Lazo, SB
    Frank, DA
    Neuberg, D
    Ritz, J
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03): : 561 - 575
  • [6] Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
    Kerkar, Sid P.
    Muranski, Pawel
    Kaiser, Andrew
    Boni, Andrea
    Sanchez-Perez, Luis
    Yu, Zhiya
    Palmer, Douglas C.
    Reger, Robert N.
    Borman, Zachary A.
    Zhang, Ling
    Morgan, Richard A.
    Gattinoni, Luca
    Rosenberg, Steven A.
    Trinchieri, Giorgio
    Restifo, Nicholas P.
    CANCER RESEARCH, 2010, 70 (17) : 6725 - 6734
  • [7] T:T antigen presentation by activated murine CD8+ T cells induces anergy and apoptosis
    Chai, JG
    Bartok, I
    Scott, D
    Dyson, J
    Lechler, R
    JOURNAL OF IMMUNOLOGY, 1998, 160 (08): : 3655 - 3665
  • [8] CD2 REGULATES RESPONSIVENESS OF ACTIVATED T-CELLS TO INTERLEUKIN-12
    GOLLOB, JA
    LI, J
    REINHERZ, EL
    RITZ, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03): : 721 - 731
  • [9] Oligoclonality of CD8+ T Cells in Breast Cancer Patients
    Koichi Ito
    James Fetten
    Houman Khalili
    Steven Hajdu
    Erna Busch
    Robert Pergolizzi
    Vincent Vinciguerra
    Ming-der Y. Chang
    Molecular Medicine, 1997, 3 : 836 - 851
  • [10] Oligoclonality of CD8+ T cells in breast cancer patients
    Ito, K
    Fetten, J
    Khalili, H
    Hajdu, S
    Busch, E
    Pergolizzi, R
    Vinciguerra, V
    Chang, MDY
    MOLECULAR MEDICINE, 1997, 3 (12) : 836 - 851